An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%

• Status: Completed
• Trial end date: 2008-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine the cosmetic appearance of metronidazole gel (MetroGel®) 1% with commonly marketed facial foundations.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Galderma Laboratories, L.P.
• Treatments: Metronidazole

Criteria

Inclusion Criteria:

• Subjects with moderate Rosacea (Global Severity Score of 3),

• Subjects willing to stop their current rosacea medication for at least 2 weeks

• Subjects must have an established routine of cosmetics application (e.g. must have been using the same facial foundation for at least 3 months and it is not expected to change during the study)

• Subjects must be willing to use their routine facial foundation and not change products while on study

Exclusion Criteria:

• Subjects who do not routinely wear facial foundation

• Subjects who failed to undergo a washout period of 14 days for the use of topical rosacea therapy, (for example: metronidazole, azelaic acid, sulfacetamide)

• Subjects who are unwilling to stop their current rosacea medications for 2 weeks